GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Aprogen Medicines Inc (XKRX:007460) » Definitions » Ending Cash Position

Aprogen Medicines (XKRX:007460) Ending Cash Position : ₩35,684 Mil (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Aprogen Medicines Ending Cash Position?

Aprogen Medicines's Ending Cash Position for the quarter that ended in Dec. 2023 was ₩35,684 Mil.

Aprogen Medicines's quarterly Ending Cash Position declined from Jun. 2023 (₩35,324 Mil) to Sep. 2023 (₩22,363 Mil) but then increased from Sep. 2023 (₩22,363 Mil) to Dec. 2023 (₩35,684 Mil).

Aprogen Medicines's annual Ending Cash Position increased from Dec. 2021 (₩15,894 Mil) to Dec. 2022 (₩43,070 Mil) but then declined from Dec. 2022 (₩43,070 Mil) to Dec. 2023 (₩35,684 Mil).

Aprogen Medicines Ending Cash Position Historical Data

The historical data trend for Aprogen Medicines's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprogen Medicines Ending Cash Position Chart

Aprogen Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71,671.76 96,615.61 15,893.50 43,069.50 35,684.41

Aprogen Medicines Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43,069.50 37,261.70 35,324.27 22,363.09 35,684.41

Aprogen Medicines Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Aprogen Medicines's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=43069.501+-7385.088
=35,684

Aprogen Medicines's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=22363.086+13321.327
=35,684

Aprogen Medicines Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Aprogen Medicines's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Aprogen Medicines (XKRX:007460) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Aprogen Medicines Inc (XKRX:007460) » Definitions » Ending Cash Position
Comparable Companies
XKRX:122640 XKRX:382840 XKRX:090360 XKRX:030530 XKRX:011810 XKRX:297090 XKRX:217820 XKRX:161580 XKRX:277880 XKRX:126720 GE XTER:SIE XPAR:SU ETN XKRX:373220 ITW OSTO:ATCO A EMR PH AME
Traded in Other Exchanges
N/A
Address
545, Dunchon-daero, B1 Floor, Jungwon-gu, Sangdaewon-dong, Hallasigma valley,, Gyeonggi-do, Seongnam-si, KOR
Website
https://www.aprogen.com
Aprogen Medicines Inc, formerly Aprogen KIC Inc manufactures and maintains plant equipment for the industrial furnace and oven sector. Its business divisions include plant, fired heater, hard facing, and thermal insulation works.

Aprogen Medicines (XKRX:007460) Headlines

No Headlines